Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate

Herbert Schöchl, Oliver Grottke, Ken Sutor, Kieron Dony, Martin Schreiber, Marco Ranucci, Peter W. Collins

    Research output: Contribution to journalArticle

    4 Scopus citations

    Abstract

    Prothrombin complex concentrates (PCCs) have been associated with a possible risk of thromboembolic complications, potentially attributable to an increased ratio of the plasma concentration of factor II (FII) to antithrombin (AT). We developed a mathematical model to examine the relationship between amounts of PCC or therapeutic plasma administered, and plasma levels of FII and AT. The model showed that PCC produces substantial increases in plasma levels of FII but only small changes in AT, increasing the FII:AT ratio. Therapeutic plasma was shown to have only modest effects on levels of FII or AT, unless high doses are used.

    Original languageEnglish (US)
    Pages (from-to)1471-1474
    Number of pages4
    JournalAnesthesia and analgesia
    Volume125
    Issue number5
    DOIs
    StatePublished - Nov 1 2017

    ASJC Scopus subject areas

    • Anesthesiology and Pain Medicine

    Fingerprint Dive into the research topics of 'Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate'. Together they form a unique fingerprint.

  • Cite this